We are live on ! Find out more
HAG

HighPoint Advisor Group Portfolio holdings

AUM $2.84B
1-Year Est. Return 31.94%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+31.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$281K
Cap. Flow
-$19.6M
Cap. Flow %
-6.32%
Top 10 Hldgs %
28.11%
Holding
317
New
45
Increased
102
Reduced
126
Closed
39
Avg Time Held
3.9 quarters
Top 10 Avg Time Held
4.6 quarters
Top 20 Avg Time Held
4.5 quarters

Top Buys

Rank Stock Value
1
PNC icon
PNC Financial Services
PNC
+$3.98M
2
PLD icon
Prologis
PLD
+$3.79M
3
RHI icon
Robert Half
RHI
+$3.38M
4
PSX icon
Phillips 66
PSX
+$2.95M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.74M

Sector Composition

Rank Sector Weight
1 Healthcare 14.01%
2 Technology 12.53%
3 Industrials 12.02%
4 Communication Services 11.35%
5 Financials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CBI
301
DELISTED
Chicago Bridge & Iron Nv
CBI
– –
-6,363
Closed -$210K –
CSRA
302
DELISTED
CSRA Inc.
CSRA
– –
-23,146
Closed -$702K –
MBLY icon
303
DELISTED
Mobileye N.V.
MBLY
– –
-5,450
Closed -$253K –
RAI
304
DELISTED
Reynolds American Inc
RAI
– –
-3,705
Closed -$229K –
BHI
305
DELISTED
Baker Hughes
BHI
– –
-3,369
Closed -$208K –
SPLS icon
306
DELISTED
Staples Inc
SPLS
– –
-102,732
Closed -$942K –

Similar funds

HighPoint Advisor Group's Q1 2017 Portfolio in Review

As of Q1 2017, HighPoint Advisor Group held 317 positions worth $311M, up 0.09% from $310M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

HighPoint Advisor Group withdrew a net $19.6M in Q1 2017, closing 39 positions and reducing 126 holdings. Its most notable exit was Acadia Pharmaceuticals, an estimated $1.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, HighPoint Advisor Group opened a new position in Regeneron Pharmaceuticals worth $424K.

  • HighPoint Advisor Group's largest Q1 2017 buy was Regeneron Pharmaceuticals: 7,380 shares worth $424K.
  • HighPoint Advisor Group added most to PNC Financial Services in Q1 2017, an estimated $3.98M increase.
  • HighPoint Advisor Group's biggest Q1 2017 reduction was United Parcel Service, cutting an estimated $17.5M.
  • HighPoint Advisor Group fully exited Acadia Pharmaceuticals in Q1 2017, selling an estimated $1.1M.
  • HighPoint Advisor Group's ten largest holdings make up 28% of its $311M portfolio in Q1 2017.
  • HighPoint Advisor Group opened 45 new positions and closed 39 in Q1 2017.
  • HighPoint Advisor Group's portfolio value rose 0.09% quarter-over-quarter to $311M.

Based on HighPoint Advisor Group's 13F filing for Q1 2017, filed 8 Aug 2017.